ARTV vs RIVN · $37.3M cap vs rev $1.66B
Artiva Biotherapeutics, Inc. Common Stock (ARTV) versus Rivian Automotive Inc (RIVN) — a side-by-side from cached financials, not a winner call.
Artiva Biotherapeutics, Inc. Common Stock (ARTV) is a biotechnology company listed on US.
Rivian Automotive Inc (RIVN) is a auto manufacturers company listed on NASDAQ. It is led by Robert Joseph Scaringe Ph.D..
Latest reported ARTV revenue for 2025-12-31 was $0. Net income was -$83.9M. Revenue was down 100.0% from 2024-12-31 to 2025-12-31. ARTV currently screens at market cap $37.3M.
Latest reported RIVN revenue for 2026-06-30 was $1.66B. Net income was -$833.0M. Revenue was up 20.1% from 2026-03-31 to 2026-06-30. RIVN currently screens at market cap $21.81B.
ARTV currently screens at market cap $37.3M. RIVN currently screens at market cap $21.81B.
Not investment advice. Open the ARTV and RIVN stock pages for the full models.
Not investment advice.